Benchmarks ended in the red on Tuesday, dragged down by losses in technology, biotechnology and small-cap stocks. U.S. trade deficit touched its highest level in almost six and a half years, adding to the bearish sentiment. Meanwhile, investors remained concerned over fresh troubles in Greece and kept an eye on upcoming nonfarm payrolls data to gauge the timing of a […]
Benchmarks ended in the green for the second straight session on Monday boosted by a handful of upbeat earnings results. Meanwhile, investors continued to focus on economic data to gauge the timing of an interest rate hike. An expansion in the Eurozone’s manufacturing activity in April also boosted investor sentiment. The S&P 500 touched its highest level since Apr 28 […]
Stock Market Holding Well…..Stock-Markets / Stock Markets 2015May 05, 2015 – 10:08 AM GMTBy: Jack_SteimanSo yes, we saw yet another failure today when the S&P 500 got back to 2119, and turned south, but it didn’t turn south very hard. That’s good to see if you’re bullish. The market is trying to hold up better on this latest test of […]
Markets made a strong comeback on Friday as investors added beaten down stocks to their portfolios. Moreover, General Motors and Ford posted better-than-expected U.S. auto sales numbers. Economic data was mixed. Each benchmarks gained at least 1%, limiting the weekly losses.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street articleThe […]
Benchmarks finished in negative territory on Wednesday on weak GDP report while Fed retained the data-dependent stance regarding rate hike. The U.S. economy expanded at a slower pace in the first quarter due to severe winter weather, major disputes in ports and stronger dollar that adversely affected export-oriented companies. Meanwhile, investors continued to keep an eye on first quarter earnings […]
It’s been a turbulent few days for the biotech sector with the NASDAQ Biotechnology Index declining 5.46% over the last five trading days. A major part of this decline was recorded on Monday as the sector reacted to negative pipeline updates from companies like Amgen (AMGN – Analyst Report) and Celladon (CLDN – Snapshot Report). Meanwhile, Biogen’s (BIIB – Analyst […]
The biotech segment has been growing well surpassing all expectations until Monday when shares slipped significantly. The NASDAQ Biotechnology Index ^NBI and NYSE ARCA BIOTECH INDEX ^BTK had gained 16.7% and 18.7%, respectively, til Apr 24 but both declined more than 4% on Monday after disappointing news from several biotech companies.Just when news of several mergers & acquisitions, product approvals […]
Benchmarks ended the first trading session of the week in the red led by losses in biotech shares. Meanwhile, investors refrained from placing big bets ahead of the Federal Reserve meeting, which begins today. Investors also kept an eye on first quarter earnings results.For a look at the issues currently facing the markets, make sure to read today’s Ahead of […]
Benchmarks ended higher on Friday boosted by upbeat quarterly results from Amazon and Microsoft. Friday’s gains helped the S&P 500 and the Nasdaq close at record high levels. Benchmarks also ended the week on a positive note with the Nasdaq registering its biggest weekly gain since Oct 2014.For a look at the issues currently facing the markets, make sure to […]
Benchmarks finished Tuesday’s trading session mostly lower following a mixed bag of earnings reports. While, a handful of discouraging quarterly results dragged the Dow and the S&P 500 down, the Nasdaq bucked the trend banking on a new deal in the biotechnology sector.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall […]
